Timothy J. Sangiovanni, SVP, Finance & Corporate Controller at ZEVRA THERAPEUTICS, INC. (ZVRA), sold 3,000 shares at $9.18 ($28K) on 2026-02-03, disclosed to the SEC on 2026-02-04.
Scheduled sale ($28k) by SVP, Finance & Corporate Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZVRA | BUY | 2023-03-13 | $5K | — | Filing → |
| KMPH | BUY | 2020-03-16 | $800 | — | Filing → |
| KMPH | BUY | 2020-03-10 | $2K | — | Filing → |